Spineology Unveils Organization Rebrand

Spineology has unveiled a new brand and visual identity, logo, and product positioning as part of an extensive branding initiative.
 
The St. Paul, Minn.-based company said the new brand defines its flagship OptiMesh interbody fusion portfolio and establishes it in its own category.
 

OptiMesh, according to Spineology, is the only conforming, patient-specific, expandable spinal implant available on the market. It’s delivered through a very small insertion profile and dynamically conforms to a patient’s unique endplate morphology. OptiMesh also expands to one of the largest implant footprints available, the company said.
 
The technology holds an IDE level De Novo grant from the U.S. Food and Drug Administration (FDA). It touts over 20 years of clinical experience, 20 clinical publications, and over 50,000 implanted devices, Spineology boasted.

---

READ MORE: Spineology Pockets $25M in Equity Financing

---

“I am pleased to share our exciting new brand with the market,” said Amanda Bloom, Spineology’s executive VP of marketing. “This effort uniquely positions the evolution of our organization, and how clearly differentiated we are in the space. Our enhanced presence shows a more precise point of view, and better showcases the strength, and power of the OptiMesh technology.”
 
Brian Snider, Spineology’s CEO, added, “I am proud of our rich history and IDE level clinical validation. As we move to the next phase of the organization, our mission to help patients remains steadfast. This new brand accurately reflects how OptiMesh resides in a category of its own.”